Press releases
- PTC Therapeutics to Participate at Upcoming Investor Conferences
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
- PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
- PTC Therapeutics Provides Key Regulatory Updates
- PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
On Thursday, PTC Therapeutics Inc (BH3:STU) closed at 31.00, 86.75% above the 52 week low of 16.60 set on Nov 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.40 |
---|---|
High | 31.40 |
Low | 31.00 |
Bid | 30.80 |
Offer | 31.80 |
Previous close | 29.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 76.70m |
Free float | 74.88m |
P/E (TTM) | -- |
Market cap | 2.58bn USD |
EPS (TTM) | -7.69 USD |
Data delayed at least 15 minutes, as of May 02 2024.
More ▼